Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.

Keay, S; Petersen, E; Icenogle, T; Zeluff, B J; Samo, T; Busch, D; Newman, C L; Buhles, W C; Merigan, T C

Keay, S; Petersen, E; Icenogle, T; Zeluff, B J; Samo, T; Busch, D; Newman, C L; Buhles, W C; Merigan, T C.

Affiliation

Keay S; Department of Medicine, Stanford University School of Medicine, California 94305.

Rev Infect Dis ; 10 Suppl 3: S563-72, 1988.

Article in En | MEDLINE | ID: mdl-2847294

Subject(s)

Acyclovir/analogs & derivatives; Antiviral Agents/therapeutic use; Cytomegalovirus Infections/drug therapy; Heart Transplantation; Heart-Lung Transplantation; Lung Transplantation; Acyclovir/adverse effects; Acyclovir/therapeutic use; Adolescent; Adult; Antiviral Agents/adverse effects; Child, Preschool; Female; Ganciclovir; Gastroenteritis/drug therapy; Humans; Immunosuppression Therapy; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia, Viral/drug therapy; Postoperative Complications/drug therapy; Retinitis/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Acyclovir / Heart-Lung Transplantation / Heart Transplantation / Lung Transplantation / Cytomegalovirus Infections Type of study: Clinical_trials Limits: Adolescent / Adult / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Rev Infect Dis Year: 1988 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links